Telos Health is developing robotic-assisted technology to enhance the treatment of ischemic strokes, aiming to improve access to immediate care and procedural consistency. This technology addresses the critical issue of timely intervention, as currently, less than 20% of stroke patients receive the necessary immediate treatment.
Funding
Funding not disclosed
Founders
Product
Problem
Ischemic strokes require immediate treatment to minimize brain damage, but less than 20% of patients receive timely intervention due to limited access to specialized stroke centers and inconsistent procedural execution. This results in significant disparities in patient outcomes and increased long-term disability.
Solution
Telos Health is developing robotic-assisted technology designed to enhance the speed, consistency, and accessibility of ischemic stroke treatment. Their system aims to improve patient outcomes by enabling more rapid and precise intervention. The technology is intended to expand access to critical stroke care, allowing a greater number of patients to receive the immediate treatment they need, regardless of location. By focusing on procedural consistency, Telos Health seeks to reduce variability in treatment and improve the likelihood of positive outcomes for stroke patients.
Target Audience
The primary target audience includes hospitals, stroke centers, and medical professionals involved in the treatment of ischemic stroke patients.
Features
- Robotic-assisted platform for endovascular stroke procedures
- Designed to improve the speed and precision of clot removal
- Aims to expand access to stroke treatment in underserved areas
- Focus on procedural consistency to reduce variability in outcomes